Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights
NCT00850590
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Incontinence
Interventions
DRUG:
NRL001
Sponsor
Norgine